Literature DB >> 22281010

The expression analysis of mouse interleukin-6 splice variants argued against their biological relevance.

Giosuè Annibalini1, Michele Guescini, Deborah Agostini, Rita De Matteis, Piero Sestili, Pasquale Tibollo, Michela Mantuano, Chiara Martinelli, Vilberto Stocchi.   

Abstract

Alternative splicing generates several interleukin-6 (IL-6) isoforms; for them an antagonistic activity to the wild-type IL-6 has been proposed. In this study we quantified the relative abundance of IL-6 mRNA isoforms in a panel of mouse tissues and in C2C12 cells during myoblast differentiation or after treatment with the Ca(2+) ionophore A23187, the AMP-mimetic AICAR and TNF-α. The two mouse IL-6 isoforms identified, IL-6δ5 (deletion of the first 58 bp of exon 5) and IL-6δ3 (lacking exon 3), were not conserved in rat and human, did not exhibit tissue specific regulation, were expressed at low levels and their abundance closely correlated to that of full-length IL-6. Species-specific features of the IL-6 sequence, such as the presence of competitive 3' acceptor site in exon 5 and insertion of retrotransposable elements in intron 3, could explain the production of IL-6δ5 and IL-6δ3. Our results argued against biological significance for mouse IL-6 isoforms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22281010     DOI: 10.5483/bmbrep.2012.45.1.32

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  2 in total

1.  A novel splice variant of folate receptor 4 predominantly expressed in regulatory T cells.

Authors:  Yi Tian; Guoqiang Wu; Jun-Chao Xing; Jun Tang; Yi Zhang; Ze-Min Huang; Zheng-Cai Jia; Ren Zhao; Zhi-Qiang Tian; Shu-Feng Wang; Xiao-Ling Chen; Li Wang; Yu-Zhang Wu; Bing Ni
Journal:  BMC Immunol       Date:  2012-06-13       Impact factor: 3.615

2.  Accurate and precise DNA quantification in the presence of different amplification efficiencies using an improved Cy0 method.

Authors:  Michele Guescini; Davide Sisti; Marco B L Rocchi; Renato Panebianco; Pasquale Tibollo; Vilberto Stocchi
Journal:  PLoS One       Date:  2013-07-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.